Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It
can have a significant negative impact on the physical, emotional, and, psychosocial …

The reported prevalence of depression in psoriasis varies substantially. This study aims to
determine the prevalence and odds of depressive symptoms and clinical depression in …

The contribution of psychological disorders to the burden of skin disease has been poorly
explored, and this is a large-scale study to ascertain the association between depression …

Background: Little is known about how the health-related quality of life (HRQL) associated
with psoriasis compares with that of other patient populations. Objective: We describe HRQL …

We examined the prevalence of depression (measured by the Carroll Rating Scale for
Depression, CRSD), wishes to be dead and acute suicidal ideation among 480 patients with …

Objective To determine the incidence of depression, anxiety, and suicidality in patients with
psoriasis compared with the general population. Design A population-based cohort study …

Psoriasis is a chronic inflammatory systemic disease. Evidence shows an association of
psoriasis with arthritis, depression, inflammatory bowel disease and cardiovascular …

Previous studies have narrowed the interval containing PSORS1, the psoriasis-susceptibility
locus in the major histocompatibility complex (MHC), to an∼ 300-kb region containing HLA …

Background There is a high prevalence of psychiatric disorders in dermatological
outpatients. Objectives To estimate the magnitude of this problem and to identify a set of …

Background Multiple metrics evaluate the efficacy of psoriasis treatment, but interestingly,
the correlation between the mostly widely used clinical trial efficacy end point, the physician …